Back to results
US 12,747,227 B2Granted
EAAT2 activators and methods of using thereof
AssigneesOhio State Innovation Foundation, The Brigham and Women's Hospital, Inc.
InventorsKevin Hodgetts, Chien-Liang Glenn Lin
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds that activate excitatory amino acid transporter 2 (EAAT2), as well as methods of using these compounds to treat or preventing diseases, disorders, and conditions associated with glutamate excitotoxicity.
Claims4
A compound defined by Formula I
- wherein
- Y is O;
- X1 is N;
- X2 is CR3;
- X3 is CR4;
- A is pyridyl, pyrazinyl, pyrimidinyl, triazinyl, or pyridazinyl substituted by 1, 2, 3, or 4 independently selected RA groups;
- R2 is —(CHRE)nR5;
- R5 is 5-6 membered heteroaryl optionally substituted by 1 or 2 independently selected RB groups;
- RE is selected from the group consisting of H, C1-6 alkyl, C1-6 alkoxy, and amino, wherein said C1-6 alkyl is optionally substituted by 1, 2, 3, or 4 independently selected R6 groups;
- R3 and R4 are independently H;
- each RA and RB is independently selected from halo, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-4 haloalkyl, CN, NO2, ORa, SRa, C(O)Rb, C(O)NRcRd, C(O) ORa, OC(O)Rb, OC(O)NRcRd, NRcRd, NRcORd, NRcC(O)Rb, NRcC(O) ORa, NRcC(O)NRcRd, C(═NRe)Rb, C(═NRe)NRcRd, NRcC(═NRe)NRcRd, NRcS(O)Rb, NRcS(O)2Rb, NRcS(O)2NRcRd, S(O)Rb, S(O)NRcRd, S(O)2Rb, and S(O)2NRcRd;
- wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C1-4 haloalkyl are optionally substituted with 1, 2, 3, or 4 independently selected R6 groups;
- each Ra, Rb, Rc, and Rd is independently selected from H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-4 haloalkyl, C3-10 cycloalkyl, 6-10 membered aryl, 5-10 membered heteroaryl, and 4-10 membered heterocycloalkyl;
- wherein the C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-4 haloalkyl, C3-10 cycloalkyl, 6-10 membered aryl, 5-10 membered heteroaryl, and 4-10 membered heterocycloalkyl are each optionally substituted with 1, 2, 3, or 4 independently selected R6 groups;
- each Re is independently selected from H, CN, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkylthio, C1-6 alkylsulfonyl, C1-6 alkylcarbonyl, C1-6 alkylaminosulfonyl, carbamyl, C1-6 alkylcarbamyl, di(C1-6 alkyl) carbamyl, aminosulfonyl, C1-6 alkylaminosulfonyl, and di(C1-6 alkyl) aminosulfonyl;
- each R6 is independently selected from OH, NO2, CN, halo, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-4 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, cyano-C1-3 alkyl, HO—C1-3 alkyl, amino, C1-6 alkylamino, di(C1-6 alkyl) amino, thio, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, carbamyl, C1-6 alkylcarbamyl, di(C1-6 alkyl) carbamyl, carboxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 alkylcarbonylamino, C1-6 alkylsulfonylamino, aminosulfonyl, C1-6 alkylaminosulfonyl, di(C1-6 alkyl) aminosulfonyl, aminosulfonylamino, C1-6 alkylaminosulfonylamino, di(C1-6 alkyl) aminosulfonylamino, aminocarbonylamino, C1-6 alkylaminocarbonylamino, and di(C1-6 alkyl) aminocarbonylamino;
- and
- n is 1;
- or a pharmaceutically acceptable salt, ester, or N-oxide thereof.
16 more elements
Dependencies are inferred from the claim text.